Dataset from Safety and Immunogenicity Study of 2 Formulations of GSK Biologicals' Varicella Vaccines Given as a 2-dose Course in the Second Year of Life.

The purpose of this study is to evaluate the safety and immunogenicity of 2 formulations of GSK Biologicals' varicella vaccines given as a 2-dose course in the second year of life.

本研究旨在评估两款葛兰素史克生物制品（GSK Biologicals）生产的水痘疫苗制剂，采用两剂接种程序于婴儿出生后第二年内接种时的安全性与免疫原性。